Buffy Coat: Definition and Composition
The buffy coat is a critical and distinct layer that forms when a sample of anticoagulated whole blood is subjected to centrifugation. After the spinning process, the whole blood separates into three primary layers based on density: the top layer is the plasma (a clear, straw-colored liquid), the bottom layer consists of the densest components, the erythrocytes or red blood cells (RBCs), and in between these two is the thin, grayish-white to yellowish-beige layer known as the buffy coat.
The term “buffy coat” derives from its color, which is similar to buff leather. It is a concentrated suspension of the nucleated cells and cell fragments in the blood—specifically the leukocytes (white blood cells, or WBCs) and the thrombocytes (platelets). Due to its composition, the buffy coat is an indispensable resource in biomedical research and clinical diagnostics. It is incredibly sparse in volume, typically accounting for less than 1% of the total blood sample, yet it contains white blood cells and platelets at a concentration that is 10 to 20 times higher than that found in the initial whole blood volume.
The cellular components of the buffy coat include all types of leukocytes—lymphocytes, monocytes, and granulocytes (neutrophils, eosinophils, and basophils)—along with platelets. The color of the layer can sometimes vary; for instance, a green tint indicates a high concentration of neutrophils due to the presence of the green-colored enzyme myeloperoxidase.
Preparation of the Buffy Coat
The generation of a buffy coat from a whole blood sample is primarily achieved through a simple, yet meticulously controlled, laboratory procedure known as density gradient centrifugation. This process is highly effective because the different cellular elements of the blood possess varying densities, allowing gravity and centrifugal force to stratify them into distinct layers.
The preparation protocol typically starts with a whole blood sample collected using an anticoagulant, such as EDTA. The anticoagulated blood is placed into a narrow tube and subsequently centrifuged at a moderate relative centrifugal force (RCF), commonly around 800g to 1000g, for a period ranging from 10 to 25 minutes. A crucial step often employed to improve the quality of the separation is centrifuging with the brake off, which minimizes re-mixing of the layers.
Once centrifugation is complete, the layers are visible, and the experimenter carefully removes the supernatant plasma. The thin buffy coat layer, which sits immediately atop the red blood cell mass, is then collected. It is standard practice to aspirate the buffy coat along with a small portion of the plasma above it and a small layer of the red blood cells directly below it (often about 1mm depth). This inclusion of surrounding material ensures maximum recovery of the highly concentrated leukocytes and platelets. Furthermore, some specialized applications, particularly in blood banking, utilize instruments like a standard blood bank centrifuge, a blood-cell washer, or an apheresis device to automate and standardize the process.
It has been noted in clinical research that the timing of blood processing can critically impact the functional capacity of the cells. Studies comparing “Fresh Blood Buffy Coats” (processed on the day of collection) versus “Overnight Blood Buffy Coats” (processed the day after collection) show that the fresh preparation yields monocytes with a better capacity for antigen presentation and activation of immune cells like invariant Natural Killer T (iNKT) cells. Therefore, the specific protocol must be chosen carefully to suit the intended downstream application.
Key Uses in Biomedical Research and Diagnostics
The high concentration of white blood cells and platelets makes the buffy coat a vital bio-fluid with diverse applications spanning DNA analysis, immunological studies, and disease diagnostics.
One of the most significant and common applications is the isolation of genomic DNA (gDNA). Since mammalian red blood cells are anucleate (lacking a nucleus), they contain no DNA. In contrast, the concentrated white blood cells in the buffy coat are a readily available and rich source of nucleated cells, which allows for the purification of large amounts of gDNA from relatively small sample volumes. Buffy coat specimens are routinely stored for years in frozen form, serving as a DNA archive for future genetic testing and research.
For immunological research, the buffy coat is an essential source for isolating specific immune cell populations, particularly the Peripheral Blood Mononuclear Cells (PBMCs), which include lymphocytes and monocytes. These cells are fundamental for studying immune response, cell signaling, and the mechanism of various diseases. Researchers use these highly concentrated cells to conduct experiments on monocyte function, lymphocyte activity (T cells, B cells, and Natural Killer cells), and platelet behavior, which can directly inform the development of new therapeutics and patient treatment strategies.
In clinical diagnostics, the Quantitative Buffy Coat (QBC) test is a standard laboratory method used for the rapid and sensitive detection of blood parasites, such as those causing malaria, leishmaniasis, and trypanosomiasis. This method involves centrifuging blood in a QBC capillary tube coated with a fluorescent dye like acridine orange. The centrifugal stratification concentrates the fluorescing, parasitized erythrocytes at the interface between the erythrocytes and the buffy coat, allowing for easier observation and identification under fluorescence microscopy. Furthermore, the buffy coat smear technique aids medical technologists in manually performing a differential white blood cell count when automated systems or low cell counts make the process otherwise difficult or impossible.
Therapeutic and Overall Clinical Significance
Beyond its laboratory utility, the buffy coat has critical direct and indirect therapeutic applications in medicine. The high concentration of platelets allows the buffy coat to be processed further as an alternative source for platelet purification, which is then transfused to patients suffering from thrombocytopenia (low platelet counts). Buffy coat preparation is considered advantageous for platelets because it is often cheaper, quicker, and causes less platelet activation and damage compared to other isolation methods. Similarly, fresh granulocytes, another concentrated component of the buffy coat, can be isolated and used for granulocyte transfusions to aid patients with critically low white blood cell counts who are non-responsive to antibiotics, such as those with severe aplastic anemia.
The components of the buffy coat are also central to specialized medical procedures. For instance, in Extracorporeal Photopheresis (ECP), a treatment used for certain autoimmune diseases like systemic sclerosis, the procedure involves leukapheresis, UVA photo-activation of the collected buffy coat, and then re-transfusion of the treated cells. The buffy coat, therefore, serves as the vehicle for this cell-based therapy.
In conclusion, the buffy coat is far more than just a visible layer in a centrifuged blood tube. It represents a vital nexus of the human immune system and genetic material, providing a highly concentrated and accessible fraction of white blood cells and platelets. Its utility spans fundamental research (DNA extraction and immune cell study), advanced diagnostics (QBC for parasitic diseases), and direct patient care (granulocyte and platelet transfusions), underscoring its indispensable role in modern hematology and biomedical science.